Cox Christopher T 4
4 · MEDICINES CO /DE · Filed Mar 2, 2018
Insider Transaction Report
Form 4
MEDICINES CO /DEMDCO
Cox Christopher T
EVP & Chief Corp. Dev. Officer
Transactions
- Award
Common Stock
2018-03-01+15,000→ 60,943 total - Award
Common Stock
2018-02-28$26.02/sh+330$8,587→ 45,943 total
Holdings
- 171,155(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning September 1, 2017 and ending February 28, 2018. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on February 28, 2018.
- [F2]Shares of restricted stock vest in 25% increments on each anniversary of the date of grant, until fully vested.
- [F3]The reporting person holds a power of attorney with respect to this account. Members of the reporting person's immediate family may be considered to have a pecuniary interest in this account. The reporting person disclaims beneficial ownership of the shares held by this account except to the extent of his pecuniary interest therein.